ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor.

Fan Fei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.